tiprankstipranks
Trending News
More News >
Amdocs (DOX)
NASDAQ:DOX
Advertisement

Amdocs (DOX) AI Stock Analysis

Compare
530 Followers

Top Page

DOX

Amdocs

(NASDAQ:DOX)

Rating:74Outperform
Price Target:
$98.00
▲(13.24% Upside)
Amdocs' strong financial performance and positive earnings call are the most significant factors contributing to its score. While technical analysis shows neutral signals, the company's reasonable valuation and strategic advancements in cloud services and AI support a positive outlook. Challenges in revenue growth and macroeconomic uncertainties are noted but do not overshadow the company's strengths.
Positive Factors
Cloud Growth
Cloud initiatives continue to generate most of the growth, with cloud accounting for over 25% of revenues and growing at a double-digit rate.
Financial Performance
Operating margin of 21.2% increased by 310 basis points year-over-year, driven by the phasing out of non-core businesses and operating efficiencies.
Revenue Visibility
Backlog increased by $80 million quarter-over-quarter and 3.5% year-over-year on a pro forma constant currency basis, providing nearly 90% visibility for next year's revenues.
Negative Factors
Industry Challenges
The company noted continued industry spending challenges, contributing to a challenging core underlying growth.
Macro Environment
There has been no significant shift in the sluggish business trends, and the company is still experiencing an unfavorable macro environment.
Revenue Headwind
The business will face lower growth and a $600 million revenue headwind due to the discontinuation of low-margin businesses.

Amdocs (DOX) vs. SPDR S&P 500 ETF (SPY)

Amdocs Business Overview & Revenue Model

Company DescriptionAmdocs (DOX) is a leading provider of software and services for communications and media companies. With a focus on enhancing customer experience, Amdocs offers solutions that span billing, customer relationship management (CRM), and operational support systems (OSS). The company's offerings enable service providers to streamline operations, drive innovation, and deliver personalized services across various channels, including mobile, digital, and cloud environments. Amdocs serves a diverse range of clients, including telecommunications operators, cable and satellite companies, and digital service providers, operating in sectors that are increasingly reliant on technology to meet consumer demands.
How the Company Makes MoneyAmdocs generates revenue primarily through the sale of software licenses, maintenance and support services, and consulting and systems integration services. The company’s revenue model includes both recurring revenues from long-term contracts and project-based revenues from specific implementations. Key revenue streams come from its customer experience systems, billing solutions, and managed services. Amdocs has established significant partnerships with major telecommunications and media companies, which contribute to its earnings through long-term engagements and collaborations. Additionally, the company benefits from a strong demand for digital transformation services, as clients increasingly seek to modernize their operations and enhance customer engagement through advanced technology solutions.

Amdocs Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Nov 18, 2025
Earnings Call Sentiment Positive
The earnings call reflected solid financial performance with revenue growth and record achievements in Europe and Managed Services. Notable progress was made in cloud services and generative AI, contributing positively to the company's strategic goals. However, the sequential decline in backlog and ongoing macroeconomic uncertainties posed challenges. Overall, the call demonstrated a positive outlook with some caution.
Q3-2025 Updates
Positive Updates
Revenue Growth and Record Quarter in Europe
Revenue of $1.14 billion was up 3.5% year-over-year in pro forma constant currency, with sequential growth in all regions and a record quarter in Europe.
Cloud and Generative AI Commercial Progress
Amdocs experienced continued sales momentum in cloud services, winning key deals in Europe and Brazil. Additionally, commercial success in generative AI was achieved through partnerships with NVIDIA and Microsoft, and strategic deals with U.S. and UAE service providers.
Managed Services Record
Managed Services revenue was a record $771 million, up 4.1% from a year ago, accounting for roughly two-thirds of total revenue.
Strong Free Cash Flow and Shareholder Returns
Free cash flow before restructuring payments was $230 million in Q3, and the company is on track to return the majority of its free cash flow to shareholders in fiscal 2025.
Negative Updates
Backlog Sequential Decline
The 12-month backlog was down $20 million sequentially, although it was up 3% from a year ago on a pro forma basis.
Macro-Economic Uncertainty
Uncertainty due to global macroeconomic conditions, interest rate cuts, and geopolitical tensions continue to pressure spending.
Company Guidance
During the Amdocs Third Quarter 2025 Earnings Conference Call held on August 6, 2025, the company provided several key financial metrics and strategic updates. For the third quarter, Amdocs reported revenue of $1.14 billion, marking a 3.5% increase year-over-year in pro forma constant currency, surpassing the midpoint of their guidance. The quarter also saw a non-GAAP diluted earnings per share of $1.72, slightly above expectations. The company's 12-month backlog was reported at $4.15 billion, up 3% from the previous year on a pro forma basis. Amdocs highlighted its strategic advancements, particularly in cloud services and generative AI, emphasizing new deals with key partners such as Elisa in Finland and Claro Brazil. Additionally, the company maintained its full fiscal year 2025 revenue growth guidance in pro forma constant currency between 2.4% and 3.4%, with an expected non-GAAP operating margin improvement of around 300 basis points for the year. The call also noted the ongoing adoption of Amdocs' SaaS-based cloud solutions, which are contributing to its growth trajectory.

Amdocs Financial Statement Overview

Summary
Amdocs presents a strong financial profile with solid profitability and a stable balance sheet. While the company faces challenges in revenue growth, its efficient cash flow management and low leverage provide a cushion against market fluctuations. Continued focus on revenue growth and cash flow optimization will be key to sustaining its financial health.
Income Statement
75
Positive
Amdocs shows strong profitability with a consistent gross profit margin around 35-37% and a net profit margin improving to 11.96% in TTM. However, recent revenue growth has turned negative at -2.22% in TTM, indicating potential challenges in maintaining growth momentum.
Balance Sheet
80
Positive
The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.24, indicating prudent financial leverage. Return on equity is robust at 16.01% in TTM, reflecting efficient use of equity capital. The equity ratio remains stable, supporting financial stability.
Cash Flow
70
Positive
Amdocs demonstrates solid cash flow management with a free cash flow to net income ratio of 0.86 in TTM, indicating strong cash conversion. However, the operating cash flow to net income ratio has decreased, suggesting potential pressure on operational cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.65B5.00B4.89B4.58B4.29B4.17B
Gross Profit1.71B1.76B1.73B1.62B1.48B1.41B
EBITDA852.98M819.03M855.15M889.85M1.04B792.16M
Net Income554.82M493.20M540.71M549.50M688.37M497.84M
Balance Sheet
Total Assets6.33B6.39B6.43B6.39B6.51B6.34B
Cash, Cash Equivalents and Short-Term Investments342.47M514.33M742.53M817.98M965.59M983.94M
Total Debt838.64M789.74M807.31M826.83M881.17M1.03B
Total Liabilities2.79B2.89B2.86B2.83B2.88B2.68B
Stockholders Equity3.50B3.46B3.52B3.52B3.59B3.62B
Cash Flow
Free Cash Flow638.63M618.93M698.27M529.50M715.37M452.63M
Operating Cash Flow737.18M724.43M822.63M756.72M925.81M658.14M
Investing Cash Flow-28.19M-127.41M-224.50M-262.50M-329.00M-461.73M
Financing Cash Flow-759.66M-771.02M-651.43M-629.90M-870.93M315.14M

Amdocs Technical Analysis

Technical Analysis Sentiment
Negative
Last Price86.54
Price Trends
50DMA
88.71
Negative
100DMA
88.56
Negative
200DMA
87.33
Negative
Market Momentum
MACD
-0.33
Negative
RSI
48.38
Neutral
STOCH
36.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOX, the sentiment is Negative. The current price of 86.54 is below the 20-day moving average (MA) of 86.83, below the 50-day MA of 88.71, and below the 200-day MA of 87.33, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 48.38 is Neutral, neither overbought nor oversold. The STOCH value of 36.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DOX.

Amdocs Risk Analysis

Amdocs disclosed 29 risk factors in its most recent earnings report. Amdocs reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amdocs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$9.62B17.6215.75%2.31%-6.76%13.90%
71
Outperform
$11.03B27.289.21%3.98%-31.18%
68
Neutral
$7.39B17.28-60.11%-0.04%-5.07%
65
Neutral
$9.47B-6.42%33.17%82.85%
61
Neutral
$35.62B7.50-10.94%1.87%8.86%-10.27%
49
Neutral
$16.48B218.28%43.89%49.74%
49
Neutral
$11.19B-11.15%23.05%-23.69%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DOX
Amdocs
87.13
3.73
4.47%
AKAM
Akamai
78.27
-23.33
-22.96%
DBX
Dropbox
28.82
3.74
14.91%
KVYO
Klaviyo, Inc. Class A
32.08
0.58
1.84%
RBRK
Rubrik, Inc. Class A
87.53
53.76
159.19%
SAIL
SailPoint, Inc.
20.37
-4.18
-17.03%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 26, 2025